DBV Technologies S.A. DBVT
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2012-03-29
Chart by TradingView
3/9
Piotroski F — financial health
-2.63
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $5.6M | $4.2M | $15.7M | $4.8M | $5.7M |
| Operating income | -$147.1M | -$116.6M | -$76.4M | -$96.6M | -$98.6M |
| Net income | -$146.9M | -$113.9M | -$72.7M | -$96.3M | -$97.8M |
| Operating cash flow | -$121.2M | -$104.5M | -$79.7M | -$55.7M | -$108.2M |
| Free cash flow | -$121.7M | -$106.8M | -$80.3M | -$56.4M | -$109.2M |
| Total assets | $233.7M | $65.7M | $183.0M | $246.5M | $146.7M |
| Total liabilities | $64.9M | $38.3M | $42.8M | $52.1M | $47.4M |
| Shareholders' equity | $168.8M | $27.4M | $140.2M | $194.5M | $99.3M |
| Ratios | |||||
| Operating margin | -2609.2% | -2808.7% | -486.0% | -1994.9% | -1727.6% |
| Net margin | -2607.3% | -2744.4% | -462.4% | -1987.5% | -1713.5% |
| FCF margin | -2159.6% | -2573.2% | -510.7% | -1164.7% | -1912.3% |
| Return on assets | -62.9% | -173.5% | -39.7% | -39.1% | -66.7% |
| Return on equity | -87.1% | -415.8% | -51.9% | -49.5% | -98.5% |
| Debt / equity | — | — | — | — | 0.01× |
| Current ratio | 3.67 | 1.43 | 4.26 | 7.56 | 3.64 |
| Revenue growth | 35.8% | -73.6% | 224.7% | -15.1% | -49.4% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Duquesne Family Office LLC | 383,363 | $8,008 |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -2.63 (distress)
- Working capital / assets 0.663
- Retained earnings / assets -1.682
- EBIT / assets -0.629
- Equity / liabilities 2.601
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001613780 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.